Patent · US Active

Spider silk fusion protein structures incorporating immunoglobulin fragments as affinity ligands

US9856308B2 · kind B2 · utility

2Cited by

0References

21Claims

0Family size

Assignee

SPIBER TECHNOLOGIES AB · SE

Inventors

My Hedhammar · Stockholm, SE
Jan Johansson · Stockholm, SE
Anna Rising · Uppsala, SE
Per Nygren · Helsingborg, SE

Key dates

Filing date	May 2, 2013
Grant date	Jan 2, 2018
Priority date	—
Expiry date	Feb 21, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/70
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

A recombinant fusion protein comprising the moieties Band CT, and optionally REP, wherein B is comprising at least one immunoglobulin fragment, which provides the capacity of selective interaction with an organic target; CT is a moiety of from 70 to 120 amino acid residues and is derived from the C-terminal fragment of a spider silk protein; and REP is a moiety of from 70 to 300 amino acid residues and is derived from the repetitive fragment of a spider silk protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.